Event Description
Learning Objectives
At the conclusion of the activity, participants should be able to:
- Review the epidemiology of diabetes as a systemic disease.
- Discuss screening and early detection of diabetes.
- Explain systemic complications of diabetes.
- Discuss latest treatment modalities for patients with diabetes.
Target Audience
All primary care physicians and medical specialists caring for
diabetic patients, including endocrinologists, nephrologists,
ophthalmologists, nurse practitioners, physician assistants, optometrists, podiatrists,
fellows, residents, and medical, optometry, and podiatry students.
Accreditation Statement
This activity has been planned and implemented in
accordance with the Essential Areas and Policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint providership of Drexel University
College of Medicine and the Moore Eye Institute at Drexel University College of Medicine.
Drexel University College of Medicine is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Drexel University College of Medicine
designates this live activity for a maximum of 7.5
AMA PRA Category 1 Credit(s)™
. Physicians
should claim only the credit commensurate with the extent of their participation in the activity.
COPE
7.5 hours COPE Accreditation Pending, 5 qualify as TPA, 1 as glaucoma.
Faculty Disclosure Statement
It is the policy of Drexel University College of
Medicine to ensure balance, independence, objectivity and scientific rigor in all its
sponsored educational programs. Speakers at continuing medical education activities are
required to disclose to the audience, any relevant commercial interest (which is any entity
producing, marketing, reselling, or distributing health care goods or services consumed
by, or used on, patients). Any conflicts of interest must be resolved prior to the presentation
and announced to the audience. The intent of this disclosure is to allow participants to form
their own judgments about the educational content of this activity and determine whether
the speaker’s commercial interests influenced the presentation. In addition, speakers are
required to openly disclose any off-label, experimental, or investigational use of drugs or
devices discussed in their presentation.
Acknowledgements
All educational grants and exhibit funds will be acknowledged
prior to the beginning of the program.
Additional Information
Register online. For more information, contact 800.890.0000, ext. 2003
|
